Results 51 to 60 of about 548,458 (391)

Non-alcoholic fatty liver disease in polycystic ovary syndrome women

open access: yesScientific Reports, 2021
To evaluate risk factors leading to non-alcoholic fatty liver disease (NAFLD) occurrence in polycystic ovarian syndrome (PCOS) women. A retrospective cohort study of a total of 586 women diagnosed with PCOS aged 13–35 years at the gynecology department ...
Y. Won   +5 more
semanticscholar   +1 more source

Nonalcoholic Fatty Liver Disease in Women and Girls with Polycystic Ovary Syndrome.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2021
Nonalcoholic fatty liver disease (NAFLD) describes a spectrum of liver damage due to excessive hepatic lipid accumulation. Recent research has demonstrated a high prevalence of NAFLD in women with polycystic ovary syndrome (PCOS).
C. Falzarano   +6 more
semanticscholar   +1 more source

Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome [PDF]

open access: yes, 2016
There is evidence from animal and in-vitro studies that activation of the endocannabinoid system (EC) through cannabinoid receptor 1 (CB-1) is associated with liver injury, inflammation and hepatocellular carcinoma.1 Data suggests endogenous cannabinoids
Ahmed, Lina   +6 more
core   +1 more source

Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets

open access: yesLiver international (Print), 2020
Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of multiple biliary cysts. Recently, novel PLD‐causative genes, encoding for endoplasmic reticulum (ER)‐resident proteins involved in protein biogenesis and ...
A. Santos-Laso   +19 more
semanticscholar   +1 more source

Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials

open access: yesPLoS ONE, 2021
Background Uncertainty underlies the effectiveness of somatostatin analogues for slowing the progression of polycystic kidney or liver disease. Methods Eligible studies included randomized controlled trials (RCTs) evaluating somatostatin analog as ...
Tatsuya Suwabe   +4 more
semanticscholar   +1 more source

The emerging role of cellular senescence in renal diseases [PDF]

open access: yes, 2020
Cellular senescence represents the state of irreversible cell cycle arrest during cell division. Cellular senescence not only plays a role in diverse biological events such as embryogenesis, tissue regeneration and repair, ageing and tumour occurrence ...
Alpini, Gianfranco   +12 more
core   +1 more source

The role of miRNAs in the development of cholangiopathies. Part 2

open access: yesZdorovʹe Rebenka, 2023
The role of miRNA in the development of cho­langiopathies is considered in the scientific review. This article discusses the role of miRNA in biliary atresia, polycystic liver disease, and cholangiocarcinoma.
A.E. Abaturov, V.L. Babуch
doaj   +2 more sources

Role of Image Acquisition and Patient Phenotype Variations in Automatic Segmentation Model Generalization [PDF]

open access: yesarXiv, 2023
Purpose: This study evaluated the out-of-domain performance and generalization capabilities of automated medical image segmentation models, with a particular focus on adaptation to new image acquisitions and disease type. Materials: Datasets from both non-contrast and contrast-enhanced abdominal CT scans of healthy patients and those with polycystic ...
arxiv  

Simultaneous liver kidney transplantation and (bilateral) nephrectomy through a midline is feasible and safe in polycystic disease. [PDF]

open access: yesPLoS ONE, 2017
In Eurotransplant, 50% of simultaneous liver kidney transplantations (SLK) are performed for polycystic disease. Classically, liver and kidney are transplanted in two steps: liver through a subcostal incision, kidney through a separate oblique incision ...
Ina Jochmans   +4 more
doaj   +1 more source

Light chain systemic amyloidosis manifested as liver failure complicated with fatal spontaneous splenic rupture: A case report [PDF]

open access: yesarXiv, 2021
For a patient with manifestations of nausea, abdominal distension, spontaneous splenic rupture, obvious liver enlargement, low red blood cells and platelets, yellow sclera, and spider angioma, Congo red staining of liver and spleen tissues indicated amyloidosis.
arxiv  

Home - About - Disclaimer - Privacy